There’s two new studies – one that explains how the COVID-19 vaccines are beginning to cause ADE and what is happening. The second is a proposed antidote.
So first, the original study. They’re not calling it ADE. They’re calling it, “ Antibody Dependent Auto-Attack (ADAA)”.
“Pathogenic antibodies induced by spike proteins of COVID-19 and SARS-CoV viruses”
The current study revealed the pathogenic roles and the new mechanism of action (ADAA) of certain antibodies specific to the spike proteins of coronaviruses such as the COVID-19 virus and the SARS-CoV virus (Figure 8). We had discovered that in a mouse model, pre-injection of anti-influenza immune sera induced more severe infections than the mice infected with an influenza virus alone . Wang and co-workers reported that anti-SARS-CoV spike antisera promoted SARS infection through antibody-dependent enhancement (ADE) in vitro. Liu and co-workers reported that anti-SARS-CoV spike immune sera induced by a SARS-CoV vaccine caused acute lung injury by promoting MCP1 and IL-8 production and monocyte or macrophage recruitment and accumulation in SARS-CoV infected macaque models. The previously reported mechanism of action (MOA) of these anti-spike antibodies is ADE-based, in that the antibodies enhance viral infectivity.
https://europepmc.org/article/PPR/PPR357777
